North America
Deep market intelligence in the techno-commercial domain with regulatory expertise across both Canada (Health Canada) and the United States (FDA). Comprehensive understanding of NDS, ANDS, and IND/NDA pathways.
Global Pharmaceutical Excellence
Strategic Pharmaceutical Services for Global Market Entry
Novapharm Innovation Technology is a premier pharmaceutical services firm with over 70 years of combined technocratic and strategic leadership experience across North America, the United Kingdom, and Europe. We connect pharmaceutical innovation with global market opportunities.
70+Years Combined Experience
7Global Markets Covered
4Core Service Areas
$2.35TPharma Market by 2030
Global Footprint
Active Presence Across Seven Markets
Our leadership team brings deep intelligence and regulatory expertise across North America, Europe, the Middle East, South Asia, and the Asia-Pacific region.
CACanada
USUSA
UKUnited Kingdom
EUEuropean Union
MENAMiddle East & N. Africa
INIndia
AUAustralia
What We Do
Four Specialised Service Areas
An integrated portfolio of pharmaceutical services spanning the complete regulatory, scientific, and commercial lifecycle — from early formulation to global market launch.
Regulatory Affairs
MHRA, EMA, and Health Canada submission expertise — including post-Brexit compliance, hybrid applications, and centralised procedures.
Formulation & R&D
Research and development within GMP regulatory frameworks — technology transfer, scale-up, and formulation optimisation.
Intellectual Property
Patent strategy, IPR management, and freedom-to-operate analysis to protect and maximise pharmaceutical innovation value.
Project Management
End-to-end pharmaceutical project lifecycle management — from regulatory submission planning through to commercialisation and market launch.
Market Expertise
Deep Regulatory Intelligence Across Three Critical Markets
Our leadership team combines 70+ years of pharmaceutical experience across the three most complex and high-value pharmaceutical regulatory environments in the world.
United Kingdom
Post-Brexit regulatory navigation and MHRA compliance excellence — including Parallel Import licensing, Marketing Authorisation applications, and in-house pharmaceutical distribution through our UK subsidiary, NovaPharm Healthcare Ltd.
European Union
Comprehensive understanding of EMA centralised and decentralised regulatory procedures — including hybrid applications, mutual recognition procedures, and product development strategy for EU market entry.
Why Now
The Global Pharmaceutical Market Is Growing to $2.35 Trillion by 2030
At a compound annual growth rate of 6.1%, the pharmaceutical sector is one of the fastest-growing industries globally. Novapharm Innovation Technology is positioned at the centre of this growth — with the regulatory depth, scientific capability, and market intelligence to help partners capture it.
6.1%CAGR 2024–2030
$550BProjected Growth
Why Partner With Us
Seven Decades of Pharmaceutical Excellence
Three compelling reasons to choose Novapharm Innovation Technology as your strategic pharmaceutical services partner.
70+ Years Combined Expertise
Our leadership team brings unparalleled experience spanning pharmaceutical operations, regulatory affairs, formulation science, intellectual property, and commercial strategy across North America and Europe.
Technology-Enabled Delivery
Advanced digital platforms for regulatory intelligence, market analytics, and project management — enabling faster, more accurate decision-making across complex multi-market pharmaceutical programmes.
Multi-Market Regulatory Intelligence
Simultaneous capability across Health Canada, MHRA, and EMA regulatory frameworks — enabling coordinated, efficient global market entry strategies that reduce cost and timeline for pharmaceutical partners.